Sanara Ventures
VC Fund
Ra'anana, Israel
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Sanara Ventures invests in
Stages Sanara Ventures invests in
Countries Sanara Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $800k–$2.7M
- Pre-Seed
- $800k–$1M
- Series A
- $4M–$6M
Investment Focus
Industry
- Health Care 5 (56%)
- Artificial Intelligence 3 (33%)
- Medical 2 (22%)
- Software 2 (22%)
- Medical Device 2 (22%)
Stage
- Seed 2 (22%)
- Pre-Seed 2 (22%)
- Series A 2 (22%)
- Series B 1 (11%)
- Venture - Series Unknown 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Assaf Barnea
Chief Executive Officer & Founder
|
Chief Executive Officer & Founder | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $27.5M / Series B / Nov 21, 2024 | ||
| Panacea-ml revolutionizes clinical trial design with its data-driven, explainable-AI SaaS platform. Our cutting-edge technology addresses the primary causes of clinical development failure by identifying patient profiles that maximize therapeutic efficacy, minimize safety risks, and improve participant retention. Leveraging historical clinicaltrials and millions real-world patient health records, Panacea-ml's AI model enhances patient selection criteria, reduces cohort sizes, and uncovers novel marker-endpoint interrelations, surrogate markers, and causal relationships beyond simple statistical correlations.Our platform is a game-changer for the pharmaceutical industry, facilitating seamless collaboration across drug development, data science, and clinical teams. It accelerates drug development by generating precise sub-population profiles, refining patient selection criteria, and providing informed go/no-go decisions for each phase of development. Panacea-ml is versatile, supporting small sample sizes and various therapeutic domains, including rare diseases and early development stages.At Panacea-ml, we believe in empowering innovation and fostering collaboration to drive impactful outcomes. Our mission is to shorten time to market and enable early access to innovative treatments for patients worldwide. | $1M / Pre-Seed / Nov 16, 2022 | ||
| CVAid Medical develops an innovative AI based stroke detection technological platform. | $4M / Series A / Feb 23, 2022 | ||
| An early-stage startup with a mission to transform the relationship between US health plans and their aging members. We offer an end-to-end, AI-based management solution that continuously generates data insights to help Medicare Advantage health plans proactively and precisely target supplemental benefits to their aging member’s needs andpreferences, all while continuously optimizing plans to reduce health risks and expenses, improve member retention, and 5-star ratings. | $800K / Pre-Seed / Jan 01, 2022 | ||
| TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $5M / Venture - Series Unknown / Sep 29, 2021 | ||
| TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $20M / Venture - Series Unknown / Jun 07, 2021 | ||
QTflow Ltd.
|
A Micro Air Pump Technology: The Future of Thermal Management | $800K / Seed / Jun 01, 2021 | |
| Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel. | $2.7M / Seed / May 24, 2021 | ||
| TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $6M / Series A / Mar 01, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sanara Ventures invest in?
Sanara Ventures invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Seed and Pre-Seed stage. Most of the 9 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Sanara Ventures invest in?
Sanara Ventures typically joins rounds of $800k–$2.7M at Seed, $800k–$1M at Pre-Seed and $4M–$6M at Series A. These are whole funding-round sizes, not Sanara Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sanara Ventures took part in.
How do I contact Sanara Ventures?
Public channels for Sanara Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sanara Ventures?
The team at Sanara Ventures includes Assaf Barnea (Chief Executive Officer & Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
